SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Hanx Biopharmaceuticals (Wuhan) Explores AI For Drug Research With Xtalpi

Hanx Biopharmaceuticals (Wuhan) Co Ltd said it entered an agreement to explore AI for science in drug research and development and molecule design, procuring Xtalpi Science Platform services.

3378.HK